Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows

The debt offering by Pfizer to buy cancer drug maker Seagen comes as Apple, Merck and T-Mobile tap the U.S. bond market ahead of the debt ceiling standoff. 

from Health and Science https://ift.tt/PRvscoE
https://ift.tt/kgBT3nd
https://ift.tt/qEmn8Nj